UNSPSC 51172823: Epinephrine/zinc phenolsulfonate

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class OR900. This VA Drug Class (OR900) classifies this compound as belonging to the group DENTAL AND ORAL AGENTS, TOPICAL, OTHER.

UNSPSC 51172823 Epinephrine/zinc phenolsulfonate is a Commodity code covering pharmaceutical active ingredients and finished formulations supplied through state and local cooperative purchasing agreements. State and local governments buy these products primarily through multistate cooperative purchasing alliances that aggregate demand across participating jurisdictions and establish contracts with manufacturers and authorized pharmaceutical wholesalers. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, represents a primary issuing body for this commodity, leveraging cooperative purchasing vehicles to distribute generic multi-source pharmaceuticals and over-the-counter products across state and local government facilities.

MMCAP's January 2026 RFP for generic multi-source pharmaceuticals and OTC products, due March 26, 2026, is the most recent representative opportunity under this code. The procurement establishes multiple contracts with manufacturers required to supply products through three authorized wholesalers—AmerisourceBergen Drug Corporation (Cencora), Cardinal Health 110 and 112, and Morris & Dickson Co., LLC—with awarded vendors effective July 1, 2026. Vendors must certify compliance with current Good Manufacturing Practices and the Drug Supply Chain Security Act, maintain relationships with at least two of three authorized wholesalers with chargeback systems in place, and demonstrate pricing flexibility through multiple formats including flat price, net price, or WAC-minus structures. Evaluation weights pricing competitiveness at 75 percent, with the remainder split among fixed pricing, administrative compliance, EDI capability, and acceptance of a 3 percent administrative fee. All products must be available in the marketplace by May 15, 2026, carry FDA approval, possess expiration dates of at least one year from manufacture, and maintain a minimum six-month shelf life. The contract term is two years for new responders, with optional extensions at MMCAP's sole discretion, while incumbent responders' amendments extend through June 30, 2028. Geographic activity centers on Minnesota and Oregon through the MMCAP cooperative vehicle.